EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma

被引：0
|
作者：
Maria Colombino
Panagiotis Paliogiannis
Antonio Cossu
Davide Adriano Santeufemia
Maria Cristina Sini
Milena Casula
Grazia Palomba
Antonella Manca
Marina Pisano
Valentina Doneddu
Giuseppe Palmieri
机构：
[1] Institute Biomolecular Chemistry,Unit of Cancer Genetics
[2] CNR,Department of Medical, Surgical, and Experimental Sciences
[3] University of Sassari,undefined
[4] Medical Oncology Unit,undefined
[5] Civil Hospital,undefined
来源：
BMC Pulmonary Medicine | / 19卷
关键词：
Lung cancer; Adenocarcinoma; Targeted therapies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Rates of EGFR, KRAS and ALK gene changes in lung cancer patients in Croatia.
    Jakopovic, Marko
    Brcic, Luka
    Misic, Marija
    Seiwerth, Fran
    Drpa, Gordana
    Cucevic, Branka
    Plestina, Sanja
    Roglic, Mihovil
    Kukulj, Suzana
    Smojver-Jezek, Silvana
    Seiwerth, Sven
    Samarzija, Miroslav
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] Prognosis after Whole-Brain Radiotherapy for Leptomeningeal Metastasis in Patients with Lung Adenocarcinoma with or without EGFR/ALK Alterations
    Oyoshi, H.
    Hirata, H.
    Hirano, Y.
    Zenda, S.
    Fujisawa, T.
    Nakamura, M.
    Hojo, H.
    Motegi, A.
    Kageyama, S. I.
    Akimoto, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E60 - E61
  • [43] Clinical and Genetic Features in Lung Adenocarcinoma Without EGFR Mutation and ALK Rearrangement in Taiwan
    Shiao, T.
    Chiang, C.
    Luo, Y.
    Chao, H.
    Huang, H.
    Chiu, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2252 - S2253
  • [44] Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement
    Caliez, J.
    Monnet, I.
    Pujals, A.
    Rousseau-Bussac, G.
    Jabot, L.
    Boudjemaa, A.
    Leroy, K.
    Chouaid, C.
    REVUE DES MALADIES RESPIRATOIRES, 2017, 34 (05) : 576 - 580
  • [45] Targeted Deep Sequencing of EGFR/KRAS/ALK-Negative Lung Adenocarcinoma Reveals Potential Therapeutic Targets
    Lim, Sun Min
    Kim, Hye Ryun
    Moon, Yong Wha
    Kim, Joo-Hang
    Cho, Byoung Chul
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S185 - S185
  • [46] Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma
    Cai, Guoping
    Wong, Rebecca
    Chhieng, David
    Levy, Gillian H.
    Gettinger, Scott N.
    Herbst, Roy S.
    Puchalski, Jonathan T.
    Homer, Robert J.
    Hui, Pei
    CANCER CYTOPATHOLOGY, 2013, 121 (09) : 500 - 507
  • [47] Incidence of EGFR, kras, BRAF, ALK, and p53 alterations in a cohort of 218 consecutively tested patients from a certified lung cancer center: Correlation with clinical characteristics and treatment outcome
    Lueers, Anne Christina
    Halbfass, Volker
    Frenzel, Regina
    Scriba, Douglas
    Willborn, Kay
    Falk, Markus
    Hellas, Cora
    Tiemann, Markus
    Griesinger, Frank
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Lung Adenocarcinoma in Young Adults: EGFR/KRAS/ALK Mutation Status and Clinicopathological Features in 64 Patients under Age 40.
    Dogan, S.
    Jhanwar, S. C.
    Ladanyi, M.
    Zakowski, M. F.
    LABORATORY INVESTIGATION, 2011, 91 : 407A - 408A
  • [49] EGFR and KRAS Mutational Analyses in Metastatic Lung Adenocarcinoma
    Munfus-McCray, Delicia
    Askin, Frederic
    Clark, Douglas
    Adams, Christina
    Gabrielson, Edward
    Li, Qing Kay
    CANCER CYTOPATHOLOGY, 2010, 118 (05) : 369 - 369
  • [50] INCIDENCE OF EGFR, KRAS, BRAF, ALK, AND P53 ALTERATIONS IN A COHORT OF 159 CONSECUTIVELY TESTED PATIENTS FROM A CERTIFIED LUNG CANCER CENTER, CORRELATION WITH CLINICAL CHARACTERISTICS AND TREATMENT OUTCOME
    Halbfass, Volker
    Prenzel, Regina
    Scriba, Douglas
    Willborn, Kay
    Falk, Markus
    Hallas, Cora
    Tiemann, Markus
    Griesinger, Frank
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S961 - S961
12345